DRUG-SENSITIVE PULMONARY TUBERCULOSIS

Clinical trials for DRUG-SENSITIVE PULMONARY TUBERCULOSIS explained in plain language.

Never miss a new study

Get alerted when new DRUG-SENSITIVE PULMONARY TUBERCULOSIS trials appear

Sign up with your email to follow new studies for DRUG-SENSITIVE PULMONARY TUBERCULOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1 Terminated 1

TB drug dosing under the microscope: could this lead to shorter, safer treatment?

Knowledge-focused Completed

This completed Phase 3 study measured how high doses of the tuberculosis drugs rifapentine and moxifloxacin move through the body in 53 adults with TB. Participants gave multiple blood samples to track drug levels. The goal was to understand the best doses to kill TB bacteria whi…

Matched conditions: DRUG-SENSITIVE PULMONARY TUBERCULOSIS

Phase: PHASE3 • Sponsor: Centers for Disease Control and Prevention • Aim: Knowledge-focused

Last updated Jun 26, 2026 18:56 UTC

DRUG-SENSITIVE PULMONARY TUBERCULOSIS

Get alerted when new DRUG-SENSITIVE PULMONARY TUBERCULOSIS trials appear

TB drug dosing under the microscope: could this lead to shorter, safer treatment?